Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring.
Cecchin E, Orleni M, Gagno S, Montico M, Peruzzi E, Roncato R, Gerratana L, Corsetti S, Puglisi F, Toffoli G, Cecchin E, Posocco B. Cecchin E, et al. Among authors: orleni m. Int J Mol Sci. 2024 Sep 27;25(19):10453. doi: 10.3390/ijms251910453. Int J Mol Sci. 2024. PMID: 39408783 Free PMC article.
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions.
Peruzzi E, Posocco B, Gerratana L, Nuti M, Orleni M, Gagno S, De Mattia E, Puglisi F, Cecchin E, Toffoli G, Roncato R. Peruzzi E, et al. Among authors: orleni m. Front Pharmacol. 2024 Sep 6;15:1420174. doi: 10.3389/fphar.2024.1420174. eCollection 2024. Front Pharmacol. 2024. PMID: 39309010 Free PMC article.
Pharmacology and pharmacokinetics of tazemetostat.
Orleni M, Beumer JH. Orleni M, et al. Cancer Chemother Pharmacol. 2024 May;93(5):509-517. doi: 10.1007/s00280-024-04658-4. Epub 2024 Mar 23. Cancer Chemother Pharmacol. 2024. PMID: 38520556 Review.
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.
Peruzzi E, Gerratana L, Montico M, Posocco B, Corsetti S, Bartoletti M, Gagno S, Orleni M, De Mattia E, Baraldo M, Cecchin E, Puglisi F, Toffoli G, Roncato R. Peruzzi E, et al. Among authors: orleni m. Biomed Pharmacother. 2023 Nov;167:115479. doi: 10.1016/j.biopha.2023.115479. Epub 2023 Sep 19. Biomed Pharmacother. 2023. PMID: 37734262 Free article.
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure.
Roncato R, Peruzzi E, Gerratana L, Posocco B, Nuzzo S, Montico M, Orleni M, Corsetti S, Bartoletti M, Gagno S, Canil G, De Mattia E, Angelini J, Baraldo M, Puglisi F, Cecchin E, Toffoli G. Roncato R, et al. Among authors: orleni m. Biomed Pharmacother. 2023 Aug;164:114906. doi: 10.1016/j.biopha.2023.114906. Epub 2023 Jun 7. Biomed Pharmacother. 2023. PMID: 37295250 Free article.
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.
Canil G, Orleni M, Posocco B, Gagno S, Bignucolo A, Montico M, Roncato R, Corsetti S, Bartoletti M, Toffoli G. Canil G, et al. Among authors: orleni m. Pharmaceutics. 2023 May 18;15(5):1524. doi: 10.3390/pharmaceutics15051524. Pharmaceutics. 2023. PMID: 37242766 Free PMC article.
19 results